Green Pine Capital Partners (GPCP) is a venture capital firm founded in 2007. The firm was established by Fei Luo and Wei Li. It primarily operates from Shenzhen, China and it has additional offices in Beijing, Shanghai, and Guangzhou. As of February 2019, the firm has 83 companies in its portfolio and has sold off its ownership in 42 companies. Its most recent investment occurred in the same month, where the firm financed EdiGene, a company providing genome editing platform services for academia, biotechnology, and pharmaceutical companies.
Green Pine Capital Partners provides funding for companies in various stages of financing, from early-stage to initial public offering (IPO). The firm invests on companies from various sector of industries, with previous companies operating in fields such as artificial intelligence (AI), medical treatment, and e-commerce .
Funding Rounds Participated In
- Venture capitalVenture capital is a form of private equity financing that is provided by venture capital firms or funds to startups, early-stage, and emerging companies, that have been deemed to have high growth potential or which have demonstrated high growth. Capital invested usually carries a substantial element of risk.